...
首页> 外文期刊>Journal of Medical Sciences >Healing Effect of Conditioned Media from Bone Marrow-Derived Stem Cells in Thioacetamide-induced Liver Fibrosis of Rat
【24h】

Healing Effect of Conditioned Media from Bone Marrow-Derived Stem Cells in Thioacetamide-induced Liver Fibrosis of Rat

机译:骨髓干细胞条件培养基在硫乙酰胺诱导的大鼠肝纤维化中的修复作用

获取原文
           

摘要

Following repeated injury, the liver undergoes tissue remodeling and fibrosis. This study investigated the healing effect of conditioned media (secreta) from rat bone marrow-derived stem cells (BMSCs) in thioacetamide (TA)-induced liver fibrosis rat model. During 2014, thirty male Wistar rats were randomly allocated into two groups of sham control and treatment. The rats of sham control group were subdivided into three subgroups and were sampled on weeks 14, 18 and 20 after fibrosis induction. The rats of treatment group were subdivided into two subgroups and were sampled on weeks 4 and 6 after treatment by conditioned media. Fibrosis was induced by intraperitoneal administration of TA. Animals were valuated histologically and for liver function tests after TA-induced fibrosis and injection of conditioned media. Conditioned media were provided from the supernatant of BMSCs culture flasks. Administration of TA resulted into infiltration of inflammatory cells and deposition of collagen fibers in hepatic tissue. A significant healing was noticed in liver four and six weeks after post-injection of BMSCs conditioned media. Regarding fibrosis and necrosis, a significant reduction appeared 4 and 6 weeks after BMSCs conditioned media therapy. Aspartate aminotransferase (AST) and alanine transaminase (ALT) levels decreased 4 and 6 weeks after BMSCs conditioned media therapy. Regarding alkaline phosphatase (ALP) and albumin levels 4 and 6 weeks after BMSCs conditioned media therapy, a non-significant increase was seen. This study indicated that the BMSCs conditioned media had a positive healing effect in rearrangement of hepatic fibrosis. So it can be an alternative therapeutic choice to ameliorate liver fibrosis.
机译:反复受伤后,肝脏会发生组织重塑和纤维化。这项研究调查了大鼠骨髓源性干细胞(BMSC)的条件培养基(secreta)在硫代乙酰胺(TA)诱导的肝纤维化大鼠模型中的愈合作用。 2014年,将30只雄性Wistar大鼠随机分为两组,分别进行假对照和治疗。假对照组的大鼠分为三个亚组,并在诱导纤维化后的第14、18和20周取样。将治疗组的大鼠分为两个亚组,并在处理后第4和6周通过条件培养基取样。腹膜内给予TA可诱导纤维化。 TA诱导的纤维化和条件培养基注射后,对动物进行组织学评估和肝功能测试。从BMSCs培养瓶的上清液提供条件培养基。 TA的施用导致炎性细胞浸润和胶原纤维在肝组织中的沉积。注射BMSCs条件培养基后四周和六周,肝脏出现了明显的愈合。关于纤维化和坏死,BMSCs条件培养基治疗后4周和6周出现了明显的减少。 BMSCs条件培养基治疗后4周和6周,天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)含量降低。关于碱性磷酸酶(ALP)和白蛋白水平在BMSCs条件培养基治疗后4周和6周,未见明显增加。这项研究表明,BMSCs条件培养基对肝纤维化的重排具有积极的治愈作用。因此,它可以是改善肝纤维化的另一种治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号